Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates

Vox Sanguinis

Volumn 83, Issue 2, 2002, Pages 125-136

  Wadhwa, Meenu ^a   Krailadsiri, P ^b   Dilger, P ^a   Das, R Gaines ^a   Seghatchian, M J ^b   Thorpe, R ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Cytokines; Platelet concentrates; Storage; WBC reduction

Indexed keywords

CYTOKINE; INTERLEUKIN 8; RANTES; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA1;

APHERESIS; ARTICLE; CELL VIABILITY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEUKOCYTE COUNT; MEASUREMENT; PERFORMANCE; PRIORITY JOURNAL; QUALITY CONTROL; THROMBOCYTE PRESERVATION; TIME SERIES ANALYSIS; UNITED KINGDOM;

BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL SEPARATION; CYTOKINES; FILTRATION; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; PLATELET ACTIVATION; PLATELET TRANSFUSION; PLATELETPHERESIS; QUALITY CONTROL; TIME FACTORS;

EID: 0038391106     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2002.00203.x     Document Type: Article

References (46)

1. Palmer DS, Aye MT, Dumont L, Dumont D, McCombie N, Giulivi A, Rutherford B, Trudel E, Hashemi-Tavoularis S: Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system. Vox Sang 1998; 75:115-123
2. Hagberg IA, Akkok CA, Lyberg T, Kjeldsen-Kragh J: Apheresis-induced platelet activation: comparison of three types of cell separators. Transfusion 2000; 40:182-192
3. Krailadsiri P, Seghatchian J, Williamson LM: Platelet storage lesion of WBC-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations. Transfusion 2001; 41:243-250
4. Shiba M, Tadokoro K, Sawanobori M, Nakajima K, Suzuki K, Juji T: Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion 1997; 37:457-462
5. Wallvik J, Suontaka AM, Blomback M: Proteolytic activity during storage of platelets in plasma. Transfus Med 1992; 2:135-142
6. Murphy P: The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994; 12:593-633
7. Metcalfe P, Williamson LM, Reutelingsperger CP, Swann I, Ouwehand WH, Goodall AH: Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 1997; 98:86-95
8. Divers SG, Kannan K, Stewart RM, Betzing KW, Dempsey D, Fukuda M, Chervenak R, Holcombe RF: Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates. Transfusion 1995; 35:292-297
9. Aye MT, Palmer DS, Giulivi A, Hashemi S: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995; 35:117-124
10. Stack G, Snyder EL: Cytokine generation in stored platelet concentrates. Transfusion 1994; 34:20-25
11. Bubel S, Wilhelm D, Entelmann M, Kirchner H, Kluter H: Chemokines in stored platelet concentrates. Transfusion 1996; 36:445-449
12. Wadhwa M, Seghatchian M, Lubenko A, Contreras M, Dilger P, Bird C, Thorpe R: Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 1996; 93:225-234
13. Wadhwa M, Seghatchian MJ, Dilger P, Sands D, Krailadisiri P, Contreras M, Thorpe R: Cytokines in WBC-reduced apheresis PCs during storage: a comparison of two WBC-reduction methods. Transfusion 2000; 40:1118-1126
14. Muylle L, Wouters E, Peetermans ME: Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996; 36:886-890
15. Kluter H, Muller Steinhardt M, Danzer S, Wilhelm D, Kirchner H: Cytokines in platelet concentrates prepared from pooled buffy coats. Vox Sang 1995; 69:38-43
16. Klinger MH, Wilhelm D, Bubel S, Sticherling M, Schroder JM, Kuhnel W: Immunocytochemical localization of the chemokines RANTES and MIP-1α within human platelets and their release during storage. Int Arch Allergy Immunol 1995; 107:541-546
17. Krailadsiri P, Seghatchian J, Amiral J, Vissac AM, Contreras M: Annexin V, a new marker of platelet storage lesion: correlation with dMPV. Transfus Sci 1997; 18:223-226
18. Wadhwa M, Bird C, Page LA, Mire-Sluis AR, Thorpe R: Quantitative biological assays for individual cytokines; in Balkwill FR (ed.): Cytokines: a Practical Approach, edn 3. Oxford, IRL Press, 2000:207-239
19. Gaines Das RE, Rice LR: SCAN, an exploratory program for preliminary analysis of bioassay and immunoassay data. Comput Methods Programs Biomed 1985; 21:25-33
20. Muylle L, Wouters E, De Bock R, Peetermans ME: Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transjus Med 1992; 2:289-293
21. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME: Increased tumour necrosis factor a (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF-α and IL-6 levels and febrile transfusion reactions. Tranfusion 1993; 33:195-199
22. Federowicz I, Barrett BB, Andersen JW, Urashima M, Popovsky MA, Anderson KC: Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996; 36:21-28
23. Ferrer F, Rivera J, Corral J, Gonzalez Conejero R, Vicente V: Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration. Vox Sang 2000; 78:235-241
24. Kluter H, Bubel S, Kirchner H, Wilhelm D: Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39:1179-1184
25. Fujihara M, Ikebuchi K, Wakamoto S, Sekiguchi S: Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-beta1 in apheresis platelet concentrates during storage. Transfusion 1999; 39:498-505
26. Clemetson KJ, Clemetson JM, Proudfoot AEI, Power CA, Baggiolini M, Wells TNC: Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000; 96:4046-4054
27. Bertolini F, Rebulla P, Porretti L, Sirchia G: Comparison of platelet activation and membrane glycoprotein Ib and IIb-IIIa expression after filtration through three different leukocyte removal filters. Vox Sang 1990; 59:201-204
28. Pedigo M, Wun T, Paglieroni T: Removal by white cell-reduction filters of activated platelets expressing CD62. Transfusion 1993; 33:930-935
29. Fournel JJ, Zingsem J, Riggert J, Muylle L, Muller N, Kohler M, Beaumont JL, Baeten M, Eckstein R, van Waeg G: A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997; 37:487-492
30. Holme S, Andres M, Goermar N, Giordano GF: Improved removal of white cells with minimal platelet loss by filtration of apheresis platelets during collection. Transfusion 1999; 39:74-82
31. Sowemimo Coker SO, Kim A, Tribble E, Brandwein HJ, Wenz B: White cell subsets in apheresis and filtered platelet concentrates. Transfusion 1998; 38:650-657
32. Triulzi DJ, Meyer EM, Donnenberg AD: WBC subset analysis of WBC-reduced platelet components. Transfusion 2000; 40:771-780
33. Gutensohn K, Alisch A, Krueger W, Kroeger N, Kuehnl P: Extracorporeal plateletpheresis induces the interaction of activated platelets with white blood cells. Vox Sang 2000; 78:101-105
34. Holme S, Sweeney JD, Sawyer S, Elfath MD: The expression of P-selectin during collection, processing and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997; 37:12-17
35. Schall TJ, Greaves DR: RANTES; in Oppenheim J, Feldman M (eds): The Cytokine Reference. San Diego: Academic Press, 2000
36. Darbonne WC, Rice GC, Mohler MA, Apple T, Hebert CA, Valente AJ, Baker JB: Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991; 88:1362-1369
37. Horuk R, Chitnis C, Darbonne W, Colby TJ, Rybicki A, Hadley TJ, Miller LH: A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261:1182-1184
38. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268:12247-12249
39. Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N, Peiper SC: Exaggerated response to endotoxin in mice lacking the Duffy atigen/receptor for chemokines (DARC). Blood 2000; 96:1681-1684
40. Wahl SM: Transforming growth factor beta in inflammation. A cause and a cure. J Clin Immunol 1992; 12:61-74
41. McCartney-Francis N, Mizel D, Wong H, Wahl LM, Wahl SM: TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors 1990; 4:27-35
42. McCartney-Francis NL, Wahl SM: Transforming growth factor β: a matter of life and death. J Leukoc Biol 1994; 55:401-409
43. Tsunawaki S, Sporn M, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-β. Nature 1988; 334:260-263
44. Jacobsen FW, Stokke T, Jacobsen SE: Transforming growth factor-beta potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 1995; 86:2957-2966
45. Kunz D, Luley C, Heim MU, Bock M: Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion 1998; 38:156-159
46. Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS: Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991; 31:409-414